Advances in Mucoadhesive Polymers and Formulations for Transmucosal Drug Delivery
Mucoadhesive polymers are widely used in the design of dosage forms for transmucosal drug delivery to the eye, respiratory, gastrointestinal and reproductive tracts. These routes of drug administration offer a number of advantages including improved drug bioavailability, reduced frequency of adminis...
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_40314 | ||
| 005 | 20210211 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20210211s2020 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-03928-753-6 | ||
| 020 | |a 9783039287536 | ||
| 020 | |a 9783039287529 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-03928-753-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Khutoryanskiy, Vitaliy |4 auth | |
| 245 | 1 | 0 | |a Advances in Mucoadhesive Polymers and Formulations for Transmucosal Drug Delivery |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (206 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Mucoadhesive polymers are widely used in the design of dosage forms for transmucosal drug delivery to the eye, respiratory, gastrointestinal and reproductive tracts. These routes of drug administration offer a number of advantages including improved drug bioavailability, reduced frequency of administration, and the avoidance for the use of injections. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a chitosan | ||
| 653 | |a maltodextrin | ||
| 653 | |a Caco-2 cells | ||
| 653 | |a alkyl lactate | ||
| 653 | |a mucosal drug delivery | ||
| 653 | |a thermogelling polymers | ||
| 653 | |a buccal mucosa drug delivery | ||
| 653 | |a drug delivery | ||
| 653 | |a triple co-culture model | ||
| 653 | |a oral lichen planus | ||
| 653 | |a mucoadhesive polymers | ||
| 653 | |a cyclodextrins | ||
| 653 | |a paediatric | ||
| 653 | |a mucoadhesion | ||
| 653 | |a nanoparticles | ||
| 653 | |a pectin | ||
| 653 | |a furosemide | ||
| 653 | |a oral lyophilisates | ||
| 653 | |a films | ||
| 653 | |a wound healing | ||
| 653 | |a pluronic f127 | ||
| 653 | |a interpolymer complexes | ||
| 653 | |a transmucosal permeations | ||
| 653 | |a Alzheimer's disease | ||
| 653 | |a biocompatibility | ||
| 653 | |a poly (vinylpyrrolidone) | ||
| 653 | |a mucosal membranes | ||
| 653 | |a scanning electron microscopic images | ||
| 653 | |a pioglitazone | ||
| 653 | |a hydrogel | ||
| 653 | |a resuspendibility | ||
| 653 | |a thermoresponsive polymers | ||
| 653 | |a mucoadhesive microspheres | ||
| 653 | |a trimethyl chitosan | ||
| 653 | |a Candida albicans | ||
| 653 | |a xanthan gum | ||
| 653 | |a omeprazole | ||
| 653 | |a texture profile analysis | ||
| 653 | |a acrylated chitosan | ||
| 653 | |a mucoadhesive | ||
| 653 | |a clotrimazole | ||
| 653 | |a clobetasol | ||
| 653 | |a Carbopol® | ||
| 653 | |a hydroxypropyl cellulose | ||
| 653 | |a electrospinning | ||
| 653 | |a chitosan derivatives | ||
| 653 | |a in vitro permeability | ||
| 653 | |a l-arginine | ||
| 653 | |a resveratrol | ||
| 653 | |a cytotoxicity | ||
| 653 | |a retention | ||
| 653 | |a thiolated hyaluronic acid | ||
| 653 | |a Carbopol | ||
| 653 | |a mucoadhesive polymer | ||
| 653 | |a rheology | ||
| 653 | |a Eudragit® E PO | ||
| 653 | |a detachment force | ||
| 653 | |a chitosan-catechol | ||
| 653 | |a controlled release | ||
| 653 | |a PLGA-PEG | ||
| 653 | |a liposphere | ||
| 653 | |a gellan gum | ||
| 653 | |a storage and loss moduli | ||
| 653 | |a thiolated chitosan | ||
| 653 | |a interpolyelectrolyte complex | ||
| 653 | |a poly(2-ethyl-2-oxazoline) | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2235 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/40314 |7 0 |z DOAB: description of the publication |